MYX 4.96% $3.83 mayne pharma group limited

Quantifying downside risks, page-157

  1. 65 Posts.
    lightbulb Created with Sketch. 7
    Full year results scheduled for 25th August.
    Still over a month away. With sentiment the way it is still plenty of time for more blood.
    I know about the potential issues of DOJ and pricing reform but still fail to see them actually affecting earnings so much. I anticipate results will come in fine and we will be back to a normal valuation around $1.50 or above but until then shorters are having a field day.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.